Imajin se yu de tek wan blɔd tina we yu dɔktɔ tɛl yu fɔ gɛt at prɔblɛm ɔ ɔda rizin. Speshali, wan drɔg we dɛn kɔl Dabigatran. Bɔt wetin yu go du if yu gɛt siriɔs aksidɛnt wantɛm wantɛm ɛn bigin fɔ blɔd bad bad wan, ɔ yu gɛt fɔ du ɔpreshɔn kwik kwik wan? Di tin dɛn we da blɔd tin de du kin mek i nɔ izi fɔ stɔp di blɔd. Na da tɛm de dis spɛshal injɛkshɔn we dɛn kɔl Idarucizumab kin kam fɔ ɛp wi.
Us kayn mɛrɛsin na Idarucizumab (Praxbind)?
Fɔ tɔk am simpul wan, Idarucizumab na antidote. Dat min se, na drɔg we de rivɛns ɔ inaktivet di akshɔn fɔ ɔda drɔg. Bɔt i nɔ de wok fɔ ɛni blɔd tin we de mek pɔsin tan. Dɛn mek am spɛshal fɔ kɔba di tin dɛn we di blɔd tin we dɛn kɔl Dabigatran kin du.
Tink bɔt Dabigatran lɛk lɔk, ɛn Idarucizumab as di ki we fit da lɔk de. we dεn gi dis injεkshכn to di bכdi, i de go dayrekt to di Dabigatran mכlikul dεm εn stכp dεm fכ wok. Dis kin mek di natura l blɔd klot prɔses go bak to nɔmal, we kin mek dɛn ebul fɔ kɔntrol di blɔd we pasmak we i gɛt imejensi. Bɔku tɛm dɛn kin yuz am fɔ:
- We pɔsin we de tek Dabigatran gɛt aksidɛnt ɛn i de blɔd we i nɔ ebul fɔ kɔntrol.
- We pɔsin we de tek Dabigatran nid fɔ gɛt ɔpreshɔn kwik kwik wan.
Tin dɛm wae yu fɔ tɛl yu dɔktɔ bifo yu gi dis mɛrɛsin
Pan ɔl we dis na imejensi mɛrɛsin, i rili impɔtant fɔ tɛl yu dɔktɔ bɔt yu mɛdikal istri, mɔ bɔt dɛn tin ya.
- If yu gɛt hereditary fructose intolerance: Dis na jɛnɛtik kɔndishɔn. Pipul wae gɛt dis sik nɔr kin ebul fɔ telɛ sɔm kayn switin, mɔr lɛk fruktose ɛn sorbitol. Bikɔs Idarucizumab gɛt sorbitol, i impɔtant fɔ tɛl yu dɔktɔ if yu gɛt dis sik.
- If yu gɛt alɛji to Idarucizumab ɔ ɔda mɛrɛsin, it, ɔ day: I impɔtant fɔ tɛl yu dɔktɔ bɔt ɛni alɛji.
- If yu gɛt bɛlɛ ɔ yu de tray fɔ gɛt bɛlɛ.
- If yu na mama we de gi pikin in bɛlɛ.
Bay dis infɔmeshɔn, di dɔktɔ go disayd if i fɔ gi yu dis mɛrɛsin ɛn aw fɔ gi yu.
Aw yu kin yuz dis mɛrɛsin?
Dis nɔto mɛrɛsin we yu kin kɛr go na os. Idarucizumab na injɛkshɔn we dɛn kin gi as infushɔn insay wan vein, lɛk salin, na ɔspitul ɔ klinik, ɔnda dɔktɔ in sɔpɔtishɔn. So, ɔltin frɔm di doz to di spid we dɛn de gi am, na di mɛdikal wokman dɛn de kɔntrol am.
Dɔktɔ ɛn nɔs dɛn go wach yu sik gud gud wan we dɛn gi yu dis mɛrɛsin ɛn afta dɛn dɔn gi yu. Dɛn kin nid bak fɔ du blɔd tɛst.
Wetin fɔ du if di doz go ɔp (ɔvados)?
Bikɔs dɛn kin gi dis mɛrɛsin ɔnda dɔktɔ in sɔpɔtishɔn na ɔspitul, di risk fɔ mek dɛn tek am pasmak nɔ kin bɔku. Bɔt if yu tink se dis dɔn apin, yu fɔ tɛl di dɔktɔ dɛn wantɛm wantɛm. Bɔku tɛm, if pɔsin tink se pɔsin gɛt pɔyzin, wi kin kɔl di Nashɔnal Pɔyzin Infɔmeshɔn Sɛnta na di Kɔlɔmbɔ Nashɔnal Ospital . Dɔn bak, if yu de na ɔspitul, dɛn kin tɛl di Imejɛnsi Tritmɛnt Yunit (ETU) wantɛm wantɛm.
Wetin na di bad tin dɛn we kin apin to pɔsin?
Lɛk ɛni mɛrɛsin, Idarucizumab kin mek sɔm pipul dɛn gɛt sayd ɛfɛkt. Sɔm pan dɛn nid fɔ go to dɔktɔ wantɛm wantɛm. Di tebul we de dɔŋ ya de sho klia wan bɔt dɛn tin ya.
| Sayd ɛfɛkt dɛn we di Idarucizumab vaysin gɛt | |
|---|---|
| Sayd ɛfɛkt dɛm wae yu fɔ ripɔt to yu dɔktɔ ɔr wɛl bɔdi biznɛsman kwik kwik wan | |
| Alɛji Riakshɔn dɛn | Skin rash, it, swel na di fes, lip ɔ tong. |
| Sayn dɛn we de sho se Blɔd dɔn Klɔt | I nɔ izi fɔ blo, di chenj we yu de si, di chɛst de pen, yu ed de at bad bad wan wantɛm wantɛm, yu de fil pen, yu de swel ɔ wam yu leg, yu nɔ go ebul fɔ tɔk, yu fes, yu an ɔ yu leg nɔ de fil fayn ɔ yu wik wantɛm wantɛm. |
| Di sayn dɛn we pɔsin kin gɛt we i nɔ gɛt bɛtɛ potashɔm | Mɔsul pen ɔ kramp, chɛst pen, diziz, fɔdɔm, at bit fast ɔ nɔ de bit ɔltɛm. |
| Ɔda | Kɔnfyus. |
| Sayd ɛfɛkt dɛn we nɔ kin siriɔs, bɔt dɛn fɔ ripɔt to di dɔktɔ if dɛn kɔntinyu fɔ de | |
| Smɔl injuri dɛn | Ed pen, fiva, kɔnstipɛshɔn. |
Tek tɛm mɔ bɔt di prɔblɛm we kin mek yu blɔd klɔt!
Dis rili impɔtant. Dis mɛrɛsin de wok bay we i de mek blɔd nɔ klot. Dɔn, di ɔndalayn kɔndishɔn (fɔ ɛgzampul, at sik) we mek yu tek Dabigatran kin put yu pan denja fɔ gɛt blɔd klɔt bak . Na dat mek yu ɛn yu dɔktɔ dɛn kin rili pe atɛnshɔn to di sayn dɛn we de sho se blɔd dɔn rɔtin we dɛn rayt na di tebul we de ɔp. If yu gɛt ɛni wan pan dɛn sik ya, yu fɔ ripɔt am wantɛm wantɛm.
Prɔblɛm kin de wit ɔda mɛrɛsin dɛn? (Intarakshɔn dɛn)
Di gud tin bɔt dis drɔg na dat i rili spɛshal. Dis min se bikɔs na Dabigatran nɔmɔ i de tɔch, di chans nɔ de fɔ mek i gɛt intarakshɔn wit ɔda mɛrɛsin, ɛvbɔdi, ɔ sɔpɔtmɛnt.
Bɔt i rili impɔtant fɔ tɛl yu dɔktɔ bɔt ɔl di mɛrɛsin dɛn we yu de tek, ilɛksɛf na dɔktɔ gi yu, mɛrɛsin dɛn we yu nɔ de bay, vaytamɛn, tradishɔnal mɛrɛsin, ɔ ɛni ɔda tin we yu de tek. Dis kin ɛp fɔ mek dɛn nɔ gɛt prɔblɛm dɛn we nɔ nid fɔ apin.
Mɛsej we dɛn kin kɛr go na os
- Idarucizumab na spɛshal antidote injɛkshɔn we dɛn kin yuz fɔ rivɛns di ifɛkt dɛn we di drɔg we de mek blɔd tan, we dɛn kɔl Dabigatran, ɛn dɛn kin gi am we i gɛt ɛnitin fɔ du wit am.
- Dis nɔto mɛrɛsin fɔ yuz na os. Na ɔspitul nɔmɔ dɛn kin gi am we dɔktɔ dɛn de wach am.
- Ɔltɛm tɛl yu dɔktɔ bɔt ɛni sik we yu gɛt frɔm yu mama ɛn papa (especially Hereditary Fructose Intolerance) ɛn alɛji we yu gɛt.
- Afta dɛn dɔn gɛt dis vaysin, risk de fɔ mek blɔd klɔt bak. So yu fɔ no bɔt di sayn dɛn lɛk we yu de fil pen na yu chɛst, i nɔ izi fɔ blo, ɛn yu leg dɛn de swel.
- If yu gɛt ɛni kwɛstyɔn bɔt dis mɛrɛsin, nɔr frayd fɔ tɔk to yu dɔktɔ.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt